Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of lipid-formulated amphotericin B during albumin dialysis
2005-003406-28Phase 4Completed
- Sponsor
- Medical University of South Carolina
- Start
- Sep 2005
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of amphotericin b cholesteryl sulfate complex and amphotericin b in mycoses, cholestatic disease and chronic kidney disease (CKD), sponsored by Medical University of South Carolina. Primary endpoints: Cmax of lipid-formulated amphotericin B, Cmin of lipid-formulated amphotericin B and 5 more. Started Sep 2005; status: completed.
02
Drugs
amphotericin b cholesteryl sulfate complexamphotericin b
03
Conditions
mycosescholestatic diseasechronic kidney disease (CKD)
Beyond the preview
Go deeper on 2005-003406-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003406-28.